Jaslok Hospital and Research Centre is a private hospital located in Mumbai was founded by philanthropist Seth Lokoomal Chanrai along with surgeon Shantilal Jamnadas Mehta. The hospital was formally inaugurated on 6 July 1973 by the erstwhile Prime Minister, Indira Gandhi.

There are 343 beds in Jaslok Hospital and research centre.

During the past decade, Jaslok Hospital and research centre conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jaslok Hospital and research centre" #1 sponsor was "Bayer" with 2 trials, followed by "Erydel" with 2 trials sponsored, "Jaslok Hospital and Research Centre" with 2 trials sponsored, "Piramal Enterprises Limited" with 2 trials sponsored and "BioLineRx, Ltd." with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jaslok Hospital and research centre" #1 collaborator was "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator, "Cardialysis BV" with 1 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Jaslok Hospital and research centre" are "Breast Cancer" (2 trials), "Alzheimer Disease" (1 trials), "Antiplatelet Drugs" (1 trials), "Ataxia Telangiectasia" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Jaslok Hospital and research centre" in a lesser frequency.

Most popular intervention types in "Jaslok Hospital and research centre" are "Drug" (22 trials), "Other" (3 trials), "Device" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "placebo" (4 trials), "P276-00" (2 trials), "Androgen deprivation therapy (ADT)" (1 trials) and "Asacol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jaslok Hospital and research centre" are 26 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Jaslok Hospital and research centre". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Jaslok Hospital and research centre, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Jaslok Hospital and research centre, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".

Jaslok Hospital and research centre has several departments that took part in Clinical trials: "Department of Medical Oncology, Jaslok Hospital and Research Centre" - 2 trials